UP govt committed to pharma, biotech sector growth: Minister

Published On 2018-02-23 04:15 GMT   |   Update On 2018-02-23 04:15 GMT

Lucknow: Union minister of state for health and family welfare Anupriya Patel said the present state government is serious about the development of pharmaceutical and biotechnology sector.


Addressing the special plenary on pharmaceutical and biotechnology on the first day of UP Investors Summit, Patel said, "The summit will pave the path for development in the state. Development of UP will speed up development of the country."


UP minister for Medical and Health, Siddharth Nath Singh said that effective steps are been taken to promote healthcare and pharmaceutical sector in the state.


He added that 34 investors have signed MoUs of Rs 6,970 crore for this sector during the summit today. Of these, MoUs of Rs 5,743 crore has been signed under the healthcare sector and MoUs of Rs 1,227.55 crore for the pharmaceutical sector.


He said that healthcare centers will be set up in Greater Noida, Noida, near Yamuna Expressway, Lucknow, Mathura, Ghaziabad, and Moradabad.


The pharmaceutical units will be set up in Lucknow, Moradabad, Noida, Jhansi, Hamirpur, Sitapur, Kushinagar, Lakhimpur Kheri and Meerut.


UP minister for alternate energy, Brijesh Pathak, while addressing a session on renewable energy said, "The state government is all set to provide electricity to every household in the state.

Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News